Dr.Micaela Hernberg (Clinical oncologist)– Best Costs, Reviews – Book Your Consultation

Professional Experience

• Current Role: Head Physician, Head of Division of Solid Tumors, HUS Comprehensive Cancer Center
• Associate Professor: Clinical Oncology, University of Helsinki
• Previous Positions: Various clinical and research roles at Helsinki University Hospital
• Leadership Roles: Member of the Editorial Team for Acta Oncologica

Academic Contributions

• Teaching Positions: Associate Professor in Clinical Oncology at the University of Helsinki
• Research Interests: Melanoma, uveal melanoma, immunotherapy, tumor microenvironment, and cancer biomarkers
• Publications: Over 80 peer-reviewed articles in international journals
• Editorial Roles: Member of the Editorial Team for Acta Oncologica

Areas of Expertise

Dr. Hernberg specializes in:

• Melanoma: Diagnosis and treatment of cutaneous and mucosal melanoma
• Uveal Melanoma: Management of primary and metastatic uveal melanoma
• Immunotherapy: Application of immune checkpoint inhibitors and other immunotherapeutic agents
• Cancer Biomarkers: Identification and validation of prognostic and predictive biomarkers

Publications and Research

Dr. Hernberg has authored numerous publications, including:

• Rantala, E. S., Hernberg, M., et al. (2022): “Metastatic uveal melanoma: The final frontier.” Progress in Retinal and Eye Research. doi:10.1016/j.preteyeres.2022.101041
• Heino, P. J., Pappinen, J., Hernberg, M., et al. (2025): “Health-related Quality of Life and hospital costs of Finnish melanoma patients participating in the second Multicenter Selective Lymphadenectomy Trial (MSLT-II).” Acta Oncologica. doi:10.1080/0284186X.2025.42314
• Hernberg, M., et al. (1999): “Lymphocyte subsets as prognostic markers for cancer patients receiving immunomodulative therapy.” Medical Oncology. doi:10.1007/BF02906126

Patient Care Philosophy

Dr. Hernberg is committed to providing compassionate and personalized care to her patients. Her approach includes:

• Patient-Centered Care: Prioritizing the needs and preferences of patients in treatment planning
• Clear Communication: Ensuring patients are well-informed about their diagnosis and treatment options
• Multidisciplinary Collaboration: Working closely with a team of specialists to deliver comprehensive care
• Support for International Patients: Offering online consultations and support for patients from abroad

Professional Affiliations

• University of Helsinki: Associate Professor in Clinical Oncology
• HUS Comprehensive Cancer Center: Head Physician, Head of Division of Solid Tumors
• Acta Oncologica: Member of the Editorial Team
• Finnish Cancer Center (FICAN): Member

FAQs

Is Dr. Hernberg board-certified?

Yes, she is board-certified in oncology in Finland.

What types of cancers does she treat?

Dr. Hernberg specializes in melanoma, including uveal melanoma, and other solid tumors.

Does she treat international patients?

Yes, Dr. Hernberg offers online consultations and supports international patients seeking treatment.

How long is the typical hospital stay?

The length of hospital stay varies depending on the treatment plan and individual patient needs.

What languages does she speak?

Dr. Hernberg is fluent in Finnish, Swedish, and English.